Peters S P, MacGlashan D W, Schulman E S, Schleimer R P, Hayes E C, Rokach J, Adkinson N F, Lichtenstein L M
J Immunol. 1984 Apr;132(4):1972-9.
Arachidonic acid metabolism has been explored in preparations of purified human lung mast cells prelabeled with arachidonic acid (AA). Cells were of 83 to greater than 96% purity, and each experiment was performed with four to six different preparations of mast cells. After overnight culture of the purified cells in the presence of 3H-AA, followed by extensive washing in buffer, mast cell uptake of labeled AA was 61.4 +/- 14.8 pmol/10(6) cells with 21 +/- 2.4% of the label in phospholipids, 73 +/- 2.1% in neutral lipids, and 3.6 +/- 0.8% as free AA. Analysis of the distribution of radioactivity in phospholipid classes revealed 51.4 +/- 5.5% of the label in phosphatidylcholine, 14.5 +/- 1.6% in phosphatidylinositol, 12.0 +/- 3.0% in phosphatidylethanolamine, and 9.1 +/- 2.4% in sphingomyelin, with the rest in other phospholipid classes. Challenge of these cells with an optimal concentration of anti-IgE led to the release of 20 +/- 4.0% of cellular histamine and to a reduction in labeled phosphatidylcholine and phosphatidylinositol to 75.5 +/- 8.8% and 84.2 +/- 4.5% of the control levels, respectively, (p less than 0.05); anti-IgE challenge produced no statistically significant change in the quantities of other labeled phospholipids. Activation of human lung mast cells with anti-IgE led to the release of 3.4 +/- 1.3% of the cellular 3H as AA and AA metabolites (1.5 +/- 0.6% as unmetabolized AA) in conjunction with 16 +/- 4.3% of the cellular histamine. Although activation of human lung mast cells with ionophore A23187 caused 70 +/- 1.1% histamine release, a similar quantity of AA and AA metabolites was released (a total of 4.0 +/- 0.8% with 2.3 +/- 1.5% as unmetabolized AA). Analysis of the released metabolites by liquid scintillation spectrometry after high performance liquid chromatography separation showed that approximately equal amounts of metabolites were produced after mast cell activation with anti-IgE and ionophore A23187. In this series of experiments approximately equal amounts of cyclooxygenase and lipoxygenase products were generated.(ABSTRACT TRUNCATED AT 400 WORDS)
花生四烯酸代谢已在预先用花生四烯酸(AA)标记的纯化人肺肥大细胞制剂中进行了研究。细胞纯度为83%至大于96%,每个实验使用四至六种不同的肥大细胞制剂进行。在3H-AA存在下将纯化细胞过夜培养,然后在缓冲液中充分洗涤后,标记AA的肥大细胞摄取量为61.4±14.8 pmol/10(6)个细胞,其中21±2.4%的标记物存在于磷脂中,73±2.1%存在于中性脂质中,3.6±0.8%为游离AA。对磷脂类中放射性分布的分析显示,51.4±5.5%的标记物存在于磷脂酰胆碱中,14.5±1.6%存在于磷脂酰肌醇中,12.0±3.0%存在于磷脂酰乙醇胺中,9.1±2.4%存在于鞘磷脂中,其余存在于其他磷脂类中。用最佳浓度的抗IgE刺激这些细胞导致20±4.0%的细胞组胺释放,并且标记的磷脂酰胆碱和磷脂酰肌醇分别降至对照水平的75.5±8.8%和84.2±4.5%(p小于0.05);抗IgE刺激在其他标记磷脂的量上未产生统计学上显著的变化。用抗IgE激活人肺肥大细胞导致3.4±1.3%的细胞3H以AA和AA代谢物的形式释放(1.5±0.6%为未代谢的AA),同时伴有16±4.3%的细胞组胺释放。尽管用离子载体A23187激活人肺肥大细胞导致70±1.1%的组胺释放,但释放的AA和AA代谢物量相似(总共4.0±0.8%,其中2.3±1.5%为未代谢的AA)。在高效液相色谱分离后通过液体闪烁光谱法分析释放的代谢物表明,用抗IgE和离子载体A23187激活肥大细胞后产生的代谢物量大致相等。在这一系列实验中,产生的环氧化酶和脂氧化酶产物量大致相等。(摘要截短至400字)